Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

Journal of the National Cancer Institute

Volumn 91, Issue 24, 1999, Pages 2081-2086

  Calais, Gilles ^h   Alfonsi, Marc ⁱ   Bardet, Etienne ^a   Sire, Christian ^b   Germain, Thierry ^c   Bergerot, Philippe ^d   Rhein, Béatrix ^e   Tortochaux, Jacques ^f   Oudinot, Patrick ^g   Bertrand, Philippe ⁱ  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b Centre Hospitalier de Lorient   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d Centre Etienne Dolet   (France)

^e LIMOGES UNIVERSITY HOSPITAL   (France)

^f CENTRE JEAN PERRIN   (France)

^g Guillaume le Conquérant Center   (France)

^h CHU BRETONNEAU   (France)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OROPHARYNX CANCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0033572407     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.24.2081     Document Type: Article

References (26)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324: 1685-90.
2. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9.
3. Harari PM. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol 1997;15:2050-5.
4. Jeremic B, Shibamoto Y, Stanisavljevic B, Milojevic L, Milicic B, Nikoloic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 1997;43:29-37.
5. Haselow RE, Warshaw MG, Okin MM, Adams GL, Aughey JL, Cooper JS, et al. Radiation alone versus radiation plus weekly low-dose cis-platinum in unresectable cancer of the head and neck. In: Fee WE, Goepfert H, Johns ME, Strong EW, Ward PH, editors. Head and neck cancer. 1st ed. Toronto (Canada): Marcel Dekker; 1990. p. 279-81.
6. Browman GP, Cripps C, Ian Hodson D, Eapen L. Sathya J, Levin MN. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994;12:2648-53.
7. Merlano M. Corvo R, Margarino G, Benasso M, Rosso R, Sertoli MR, et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer 1991;67:915-21.
8. Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992;327: 1115-21.
9. Taylor SG, Murthy AK. Vannetzel JM, Colin P, Dray M, Caldarelli DD, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994;12:385-95.
10. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
11. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. Meta-analysis of prospective and randomized trials. J Clin Oncol 1996;14: 838-47.
12. Bourhis J, Pignon JP, Designe L, Luboinski M, Guerin S, Domenge C. Meta-analysis of chemotherapy in head and neck cancer (Mach-nc): locoregional treatment versus same treatment + chemotherapy [abstract]. Proc ASCO; 1998. p. 1486.
13. Scalliet P, De Footer C, Hellemans PW, De Bruijn EA, Van Oosterom AT. Interactions entre le Carboplatine, le Cisplatine et les radiations ionisantes dans une lignee humaine de cellules de cancer ovarien. Cancer Radiother 1999;3:30-8.
14. International Union Against Cancer (UICC). TNM classification of malignant tumours. 4th ed. In: Hermanek P, Sobin LH, editors. Heidelberg (Germany): Springer-Verlag; 1987.
15. Dose specification for reporting external beam therapy with photons and electrons. ICRU report 29. Washington (DC): International Commission on Radiation Units and Measurements; 1978.
16. Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer. Update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987;5:1410-8.
17. Eschwege F, Sancho-Garnier H, Gerard JP, Madelain M, DeSaulty A, Jortay A, et al. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCl Monogr 1988;6:275-8.
18. Gupta NK, Pointon RC, Wilkinson PM. A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neclt cancer. Clin Radiol 1987;38:575-81.
19. Haffty BG, Son YH, Papac R, Sasaki CT, Weissberg JB, Fischer D, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials. J Clin Oncol 1997;15:268-76.
20. Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BG, Wanamaker JR, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19: 567-75.
21. Yang LX, Douple E, Wang HJ. Irradiation-enhanced binding of carboplatin to DNA. Int J Radiat Biol 1995;68:609-14.
22. Horiot JC, Le Fur R, N'Guyen T, Chenal C, Schraub S, Alfonsi S, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
23. Horiot JC, Bontemps P, Begg AC, LeFur R, Van Den Bogaert W, Bolla M, et al. Radiothepic hyperfractionnee et acceleree dans les cancers de la tete et du cou: resultats des essais de l'EORTC and impact sur la pratique clinique. Bull Cancer Radiother 1996;83:314-20.
24. Wendt TG. The radiochemotherapy of advanced head-neck tumors. What is certain? Strahlenther Onkol 1996;172:409-16.
25. Weissler MC, Melin S, Sailer SL, Qaqish BF, Rosenman JG, Pillsbury HC 3rd. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992;118:806-10.
26. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338: 1798-804.